Thursday, November 3, 2016

DEA Action Continues Catch-22 of Marijuana Research

 By Lynn R. Webster, MD at PainMedicineNews

 

... "In theory, the DEA supports efforts to research the medical potential of marijuana—an agency representative pointed out that the DEA has never denied a request to conduct research that was filed using FDA protocols. However, the DEA may be operating with a law enforcement bias in keeping with its role to enforce the CSA and, perhaps, reinforcing a stigma that dates from the Nixon administration (the 1970s) when the agency was charged with preventing drug abuse." ...


No comments:

Post a Comment